Gastroenterology Month in Review: January 2024 : vimarsana.c

Our January 2024 Month in Review spotlights the FDA approval of a new indication of dupilumab (Dupixent) for pediatric eosinophilic esophagitis, new clinical trial data, and research about the prevention and management of IBD.

Related Keywords

Evan Dellon , Dupilumab Dupixent , Julie Khlevner , Drug Administration , University Of North Carolina Chapel Hill , Contemporary Pediatric , Esophageal Diseases , North Carolina Chapel Hill , Pediatric Gastrointestinal Motility Center , Columbia University Medical Center , Ibd , Inflammatory Bowel Disease , Constipation , Linaclotide , Eosinophilic Esophagitis , Dupilumab , Bustekinumab , Ulcerative Colitis ,